Meeting
2023 ASCO Genitourinary Cancers Symposium
Radical radiotherapy for muscle-invasive bladder cancer: A single centre experience.
Authors
Mayumi Forster
The Royal Free Hospital, London, United Kingdom
Mayumi Forster , Ami Mehta , Amy Clifford , Sarah Needleman , Sonia Mansukhani , Mark Prentice
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 519)
DOI
10.1200/JCO.2023.41.6_suppl.519
Abstract #
519
Poster Bd #
L3
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Increasing use of neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC): Prognostic impact of non-standard of care (SOC) regimens.
First Author: Yaw A. Nyame
Poster
2014 Genitourinary Cancers Symposium
Radical cystectomy versus trimodality bladder-preserving therapy for muscle-invasive bladder cancer among elderly (80-84 years old) patients.
First Author: Shingo Hatakeyama
Poster
2024 ASCO Genitourinary Cancers Symposium
Bladder-sparing treatment for muscle-invasive bladder carcinoma: A single-center, single-arm clinical study of sequential neoadjuvant chemotherapy followed by tislelizumab neoadjuvant immunotherapy.
First Author: Yu Zeng
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Pembrolizumab, radiotherapy, and chemotherapy in neoadjuvant treatment of malignant esophago-gastric diseases (PROCEED): Assessment of survival and patterns of recurrence in a prospective, phase II single-arm trial.
First Author: Pooja Karukonda